C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.39 AUD
Market Closed
Updated:
May 28, 2024
Cyclopharm Ltd
Other
|
Cyclopharm Ltd
Other Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Other
AU$142.5k
|
CAGR 3-Years
36%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Other
-AU$1.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-142%
|
CAGR 10-Years
-44%
|
|
|
Cochlear Ltd
ASX:COH
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Other
-AU$104.5k
|
CAGR 3-Years
34%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Other?
Other
142.5k
AUD
142.5k
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Other amounts to 142.5k AUD.
What is Cyclopharm Ltd's Other growth rate?
Other CAGR 5Y
-17%
-17%
Over the last year, the Other growth was -68%. The average annual Other growth rates for Cyclopharm Ltd have been 36% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
